ABOUT DCAT
The Drug, Chemical & Associated Technologies Association (DCAT) powers relationships and industry knowledge for companies engaged in the business of biopharmaceutical/pharmaceutical development and manufacturing.
DCAT is a 501(c)6, not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.
Founded in 1890, DCAT has been providing a life-long collegial community for industry representatives for over 125 years.
Our Commitment to our Members
Build Relationships
By providing programs, events and services, DCAT assists its 500+ global corporate members in expanding their network of customers, suppliers and colleagues in the industry.
Host DCAT Week
By continuing to develop and expand the premier business development event for the biopharmaceutical/pharmaceutical manufacturing industry, DCAT ensures that members have a forum for high-level strategic meetings with key decision makers, timely educational programs, and important networking opportunities.
Develop Information Resources
By creating objective, expert-driven education programs and informational services, members gain insight into important industry trends, analysis and best practices.
Deliver Value
By developing innovative programs and services at affordable corporate membership rates, DCAT meets the growing needs of its members.
Our Members
Our members are global companies directly engaged in the full spectrum of the biopharmaceutical/pharmaceutical manufacturing value chain: from raw materials, intermediates, active pharmaceutical ingredients (small molecules and biologics), to formulation development, drug product manufacturing, distribution, packaging, and related supply chain services.
Our Mission Statement
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting biopharmaceutical/pharmaceutical development and manufacturing.